- Profile
- Personal Information
- Publications
Experts in Ophthalmology
Rando Allikmets PAN Shilie YANG Zhihua Xin Zhang Mohamed Abou Shousha Chrisfouad R. Alabiad Thomas Albini Eduardo Alfonso Jane Koretz Guillermo Amescua Richard M. Awdeh James Banta Audina M. Berrocal Byoung Seung Ham Hilda Capo Manjusha Rajagopala Kara M. Cavuoto Ta Chen P. Chang Victoria Chang Esen K Akpek View MorePaul Chaney
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Ophthalmology Drugs
PanOptica
United States of America
Paul Chaney is president and CEO of PanOptica, Inc., a start-up, venture-backed private biopharma company, with a mission to develop innovative ophthalmic therapeutics. Prior to co-founding PanOptica, Paul was executive vice president of OSI Pharmaceuticals and president of (OSI) Eyetech, OSI’s eyecare subsidiary. He joined Eyetech Pharmaceuticals as chief operating officer in 2003. Paul has nearly 30 years of experience in the pharmaceutical industry, including a variety of senior management positions at Pharmacia Corporation. At Pharmacia, Paul served as vice president of the Global Ophthalmology Business and as vice president of Global Pharmaceutical Ophthalmology. He began his career as a sales representative for The Upjohn Company in 1980. Paul earned a dual degree in Biological Sciences and English from the University of Delaware.
Eye diseases, vision loss, effective treatments for sight-threatening diseases, licensing and developing innovative therapeutics, diabetic retinopathy, wet age-related macular degeneration